JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Biomarker Core
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Biomarker Core
批准号:
10584555
负责人:
Rebecca Terilli Veenhuis
金额:
$27.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
未结题
起止时间:
2006-06-16 至 2027-02-28
关键词:
AnhedoniaArousal and Regulatory SystemsBayesian AnalysisBehaviorBiological AssayBiological MarkersBiological ModelsChargeChemicalsClassificationClinicalClinical TrialsCognitionCommunicationCommunitiesConsultationsCoupledDataData AnalysesDatabasesDevelopmentDimensionsDiscriminant AnalysisDrug TargetingEncyclopediasFacultyFrightGenesGenomeGoalsGrantHIVImpaired cognitionIndividualInformaticsInstitutionInterventionLeast-Squares AnalysisLipidsMachine LearningMass Spectrum AnalysisMeasuresMentorshipMetabolicMissionModelingModificationMolecular TargetNational Institute of Mental HealthNegative ValenceNeurobiologyOutcome MeasurePathway AnalysisPathway interactionsPersonsPharmaceutical PreparationsPositive ValencePre-Clinical ModelPrincipal Component AnalysisProteinsResearchResearch DesignResearch Domain CriteriaResearch PersonnelResource InformaticsResourcesSamplingSeriesServicesSignal PathwaySiteSleepSocial ProcessesSystemTechniquesTherapeuticTrainingWorkbiomarker developmentbiomarker discoverybiotypescareer developmenteffectiveness evaluationexperimental groupextracellular vesiclesfield studyinterestmachine learning algorithmmolecular targeted therapiesmultidimensional dataneuroAIDSpersonalized medicinepharmacodynamic biomarkersensorimotor systemsmall moleculesocialtherapeutic developmenttherapeutic targettooltraining opportunityvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY - BIOMARKER CORE
The JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) will focus on a CNS complications
that commonly present in PWH based on the framework of the NIMH Research Domain Criteria (RDoC) that
classifies CNS complications based on dimensions of observable behavior and neurobiological measures that
include Negative and Positive Valence Systems (e.g., anhedonia, fear), Sensorimotor Systems, Systems for
Social Processes (e.g., social avoidance), Arousal/Regulatory Systems (e.g., sleep), and cognition. This
framework provides new opportunities to more accurately associate biomarkers with particular symptomology
with the goal of identifying molecular targets for the development of personalized medicine approaches by the
Therapeutics and Clinical Cores. The Biomarker Core will work closely with the Therapeutic and Clinical cores
to integrate multi-dimensional data and tools such as machine learning algorithms and offer these services to
investigators interested in NeuroHIV. Technical services will include mass spectrometry analysis for metabolites,
lipids, and proteins, multiplex Meso Scale discovery assays, extracellular vesicle isolation and cargo
characterization. Informatics analyses offered will include Small Molecules Pathway Database, Kyoto
Encyclopedia of Genes and Genomes, Cytoscape, and Ingenuity Pathway Analysis. Advanced non-parametric
analyses will include a variety of multivariate modeling such as principal component analysis (PCA), partial least
squares-discriminant analysis (PLS-DA), and sparse PLS-DA analysis, Significance analysis of metabolites
(SAM), and Empirical Bayesian analysis of metabolites (EBAM) models to identify features that discriminate
clinical biotypes or experimental groups. These services will be communicated broadly to the NeuroHIV
community through our multicenter weekly seminar series. These services are unique to the JHU CAHN, and
provide a valuable resource to NeuroHIV investigators at all stages of career development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques
-
批准号:10326649
-
项目类别:
-
资助金额:$80.73万
-
财政年份:2021
-
负责人:Rebecca Terilli Veenhuis
-
依托单位:
Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques
-
批准号:10448236
-
项目类别:
-
资助金额:$72.39万
-
财政年份:2021
-
负责人:Rebecca Terilli Veenhuis
-
依托单位:
Defining sex-based differences in the replication-competent myeloid reservoir in virally suppressed people with HIV and SIV-infected ART-suppressed macaques
-
批准号:10627964
-
项目类别:
-
资助金额:$71.49万
-
财政年份:2021
-
负责人:Rebecca Terilli Veenhuis
-
依托单位: